Dimension

Hello World. We're excited to launch Dimension today! Dimension is a first-of-its-kind firm partnering with founders at the interface of technology & life sciences to transform the trajectory of life on earth. For a decade we've honed our investment instincts & philosophies at the cutting edge of life science & technology & have stitched together a new ilk of enterprise alongside many of the planet’s greatest scientists, technologists & founders At the frontiers of the recent-possible we saw the hidden in plain sight truth: it wasn’t a question of if or when the realms of technology & life sciences would collide. They already had. Today we're announcing Dimension 1; a $350M fund investing at the earliest stages - incubation through growth - of drug discovery platforms, machine learning, tools, services, instruments & software companies digitizing the world of life sciences The digitization of life sciences will transform the entire end-to-end journey of medicines: from the Eureka moment of biological discovery, to lab tools, instruments & software, to clinical development, to regulatory interface, & ultimately to manufacturing & commercialization. And tomorrow’s biotechs will no longer be formed by a team of two: a biologist & a chemist, but instead a team of three: a biologist, chemist, & computer scientist We founded Dimension to partner with the very best entrepreneurs working across this continuum while aspiring to become a beacon and lighthouse for the greater and emerging ecosystem If this speaks to you - and our conviction is that there are MANY of you ideating, experimenting, coding & building - please reach out. We want to be on that world changing journey with you! www.dimensioncap.com

Excited to welcome Menlo Ventures & DST Global to Chai Discovery Partnering with and watching Joshua Meier, Jack Dent & the Chai team out race, out class, and out invent competitors to evolve drug DISCOVERY to drug DESIGN sets a new bar of what excellence looks like 🚀 https://xmrrwallet.com/cmx.plnkd.in/erG4p7BU

Check out the latest from Ashlee Vance at Core Memory where he chats to Jacob Kimmel from NewLimit on the future of epigenetic reprogramming. Making Old Cells Young Again. For Real "The work being done by New Limit and others in the field is, for me, the most exciting science taking place on Planet Earth" https://xmrrwallet.com/cmx.plnkd.in/ey2wyEik

Excited for Chai Discovery's latest release as we rapidly accelerate towards a world where drug discovery is designed and engineered

Shining a light on living cells 🔬💡🔬 Stately Bio is using machine learning algorithms to find the correlations between cell shapes and textures and their biological functions Congrats Frank L. on the launch 🚀 . Thrilled to have partnered with you since the very beginning! https://xmrrwallet.com/cmx.plnkd.in/eySyxrqf

Awesome to partner with Brandon White and Alex Beatson as they build Axiom Bio to deploy AI models to better predict the toxicity of drug candidates 👨🔬 💻 👩🔬 https://xmrrwallet.com/cmx.plnkd.in/e3uUjD3v

Today we’re 🚀 launching 🚀 Dimension cofounded Achira with the mission to build atomistic foundation simulation models to power the future of drug discovery. Thrilled to have partnered with amazing co-founders John Chodera and Theofanis Karaletsos and excited to have NVIDIA, Amplify Partners and Compound build alongside us 💪 Check out more at achira.ai and thank you Andrew Dunn for the coverage! https://xmrrwallet.com/cmx.plnkd.in/euJqdXQf

Will there be a singular "DeepSeek moment" for the burgeoning intersection of ML + Biology? DeepSeek's launch re-rated the value of GPU stashes, costing Nvidia over $500B in equity market cap in a single session. So, how is biology different? Will an open-source screaming meteor shatter the field's firmament and force us all to question our priors? Read more from Dimension Research Simon Barnett 👨🔬 💻 🔬 https://xmrrwallet.com/cmx.plnkd.in/eRQhXmjP

Excited to announce the promotion of Simon Barnett to Partner and Head of Research. This goes hand-in-hand with Dimension II, $500M of fresh capital, for which Simon will continue to help lead, build and invest at the frontiers of technology and science. As we transition over to Dimension II, we plan to grow our efforts in building out world class tooling and research with the mission to find ground truth in everything that we do. Much more to come! 🚀 🚀

🚨 Announcing our latest investment in Aspect Biosystems, leading their oversubscribed $115M financing 🚨 We're super excited to be partnering with Tamer Mohamed and the entire Aspect team as they lead the way in building a new class of regenerative medicines! Read more about our investment here by Nan Li https://xmrrwallet.com/cmx.plnkd.in/e62xUstK